"","V1","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","data_processing.5","data_processing.6","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","patient.id:ch1","response:ch1","sample.collection.time:ch1","tissue:ch1"
"P1065_RNA10143","GSM8797867","P1065_RNA10143","GSM8797867","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1065","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1065_RNA10143","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858846","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697352","NONE","P1065","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1065_RNA22107","GSM8797868","P1065_RNA22107","GSM8797868","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1065","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1065_RNA22107","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858845","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697353","NONE","P1065","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1065_RNA64053","GSM8797869","P1065_RNA64053","GSM8797869","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1065","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1065_RNA64053","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858844","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697354","NONE","P1065","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1134_RNA29443","GSM8797870","P1134_RNA29443","GSM8797870","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1134","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1134_RNA29443","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858843","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697355","NONE","P1134","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1134_RNA37737","GSM8797871","P1134_RNA37737","GSM8797871","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P1134","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1134_RNA37737","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858842","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697356","NONE","P1134","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1175_RNA54968","GSM8797872","P1175_RNA54968","GSM8797872","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1175","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1175_RNA54968","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858841","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697357","NONE","P1175","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1175_RNA62465","GSM8797873","P1175_RNA62465","GSM8797873","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P1175","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1175_RNA62465","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858840","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697358","NONE","P1175","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1175_RNA99644","GSM8797874","P1175_RNA99644","GSM8797874","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1175","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1175_RNA99644","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858839","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697359","NONE","P1175","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1178_RNA25160","GSM8797875","P1178_RNA25160","GSM8797875","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P1178","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1178_RNA25160","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858838","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697360","NONE","P1178","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1178_RNA58443","GSM8797876","P1178_RNA58443","GSM8797876","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P1178","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1178_RNA58443","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858837","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697361","NONE","P1178","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1178_RNA73171","GSM8797877","P1178_RNA73171","GSM8797877","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P1178","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1178_RNA73171","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858836","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697362","NONE","P1178","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1244_RNA16996","GSM8797878","P1244_RNA16996","GSM8797878","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1244","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1244_RNA16996","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858835","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697363","NONE","P1244","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1244_RNA25952","GSM8797879","P1244_RNA25952","GSM8797879","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1244","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1244_RNA25952","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858834","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697364","NONE","P1244","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1244_RNA61590","GSM8797880","P1244_RNA61590","GSM8797880","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1244","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1244_RNA61590","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858833","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697365","NONE","P1244","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1244_RNA87818","GSM8797881","P1244_RNA87818","GSM8797881","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1244","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1244_RNA87818","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858832","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697366","NONE","P1244","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1333_RNA87287","GSM8797882","P1333_RNA87287","GSM8797882","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1333","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1333_RNA87287","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858831","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697367","NONE","P1333","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1381_RNA73526","GSM8797883","P1381_RNA73526","GSM8797883","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1381","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1381_RNA73526","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858830","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697368","NONE","P1381","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1381_RNA84045","GSM8797884","P1381_RNA84045","GSM8797884","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1381","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1381_RNA84045","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858829","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697369","NONE","P1381","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1604_RNA19882","GSM8797885","P1604_RNA19882","GSM8797885","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P1604","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1604_RNA19882","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858828","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697370","NONE","P1604","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1604_RNA36583","GSM8797886","P1604_RNA36583","GSM8797886","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P1604","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1604_RNA36583","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858827","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697371","NONE","P1604","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1604_RNA37864","GSM8797887","P1604_RNA37864","GSM8797887","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1604","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1604_RNA37864","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858826","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697372","NONE","P1604","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1848_RNA24407","GSM8797888","P1848_RNA24407","GSM8797888","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1848","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1848_RNA24407","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858825","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697373","NONE","P1848","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1848_RNA44698","GSM8797889","P1848_RNA44698","GSM8797889","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1848","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1848_RNA44698","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858824","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697374","NONE","P1848","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1848_RNA97899","GSM8797890","P1848_RNA97899","GSM8797890","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P1848","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1848_RNA97899","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858823","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697375","NONE","P1848","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1854_RNA31645","GSM8797891","P1854_RNA31645","GSM8797891","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P1854","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1854_RNA31645","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858822","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697376","NONE","P1854","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1854_RNA42170","GSM8797892","P1854_RNA42170","GSM8797892","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P1854","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1854_RNA42170","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858821","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697377","NONE","P1854","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P1854_RNA97318","GSM8797893","P1854_RNA97318","GSM8797893","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P1854","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P1854_RNA97318","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858820","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697378","NONE","P1854","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2000_RNA50452","GSM8797894","P2000_RNA50452","GSM8797894","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P2000","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2000_RNA50452","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858819","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697379","NONE","P2000","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2000_RNA53397","GSM8797895","P2000_RNA53397","GSM8797895","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P2000","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2000_RNA53397","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858818","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697380","NONE","P2000","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2000_RNA62515","GSM8797896","P2000_RNA62515","GSM8797896","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P2000","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2000_RNA62515","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858817","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697381","NONE","P2000","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2060_RNA57508","GSM8797897","P2060_RNA57508","GSM8797897","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P2060","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2060_RNA57508","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858816","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697382","NONE","P2060","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2060_RNA75355","GSM8797898","P2060_RNA75355","GSM8797898","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P2060","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2060_RNA75355","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858815","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697383","NONE","P2060","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2060_RNA77171","GSM8797899","P2060_RNA77171","GSM8797899","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P2060","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2060_RNA77171","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858814","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697384","NONE","P2060","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2060_RNA80265","GSM8797900","P2060_RNA80265","GSM8797900","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P2060","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2060_RNA80265","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858813","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697385","NONE","P2060","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2482_RNA14420","GSM8797901","P2482_RNA14420","GSM8797901","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P2482","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2482_RNA14420","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858812","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697386","NONE","P2482","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2482_RNA46246","GSM8797902","P2482_RNA46246","GSM8797902","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P2482","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2482_RNA46246","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858811","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697387","NONE","P2482","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2687_RNA81791","GSM8797903","P2687_RNA81791","GSM8797903","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P2687","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2687_RNA81791","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858810","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697388","NONE","P2687","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P2819_RNA62595","GSM8797904","P2819_RNA62595","GSM8797904","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P2819","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P2819_RNA62595","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858809","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697389","NONE","P2819","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P3112_RNA35212","GSM8797905","P3112_RNA35212","GSM8797905","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P3112","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P3112_RNA35212","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858808","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697390","NONE","P3112","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P3112_RNA79212","GSM8797906","P3112_RNA79212","GSM8797906","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P3112","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P3112_RNA79212","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858807","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697391","NONE","P3112","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P3123_RNA59780","GSM8797907","P3123_RNA59780","GSM8797907","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P3123","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P3123_RNA59780","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858806","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697392","NONE","P3123","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P3123_RNA62690","GSM8797908","P3123_RNA62690","GSM8797908","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P3123","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P3123_RNA62690","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858805","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697393","NONE","P3123","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P3544_RNA74317","GSM8797909","P3544_RNA74317","GSM8797909","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P3544","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P3544_RNA74317","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858804","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697414","NONE","P3544","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P3544_RNA80675","GSM8797910","P3544_RNA80675","GSM8797910","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P3544","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P3544_RNA80675","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858803","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697415","NONE","P3544","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P3707_RNA12078","GSM8797911","P3707_RNA12078","GSM8797911","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P3707","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P3707_RNA12078","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858802","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697416","NONE","P3707","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P3707_RNA19295","GSM8797912","P3707_RNA19295","GSM8797912","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P3707","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P3707_RNA19295","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858801","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697417","NONE","P3707","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P4272_RNA28803","GSM8797913","P4272_RNA28803","GSM8797913","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P4272","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P4272_RNA28803","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858800","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697418","NONE","P4272","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P4272_RNA95536","GSM8797914","P4272_RNA95536","GSM8797914","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P4272","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P4272_RNA95536","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858799","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697419","NONE","P4272","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P4418_RNA17603","GSM8797915","P4418_RNA17603","GSM8797915","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P4418","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P4418_RNA17603","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858798","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697420","NONE","P4418","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P5665_RNA57331","GSM8797916","P5665_RNA57331","GSM8797916","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P5665","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P5665_RNA57331","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858797","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697421","NONE","P5665","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P5828_RNA63630","GSM8797917","P5828_RNA63630","GSM8797917","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P5828","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P5828_RNA63630","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858796","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697422","NONE","P5828","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P5828_RNA65889","GSM8797918","P5828_RNA65889","GSM8797918","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P5828","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P5828_RNA65889","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858795","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697423","NONE","P5828","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P5828_RNA71762","GSM8797919","P5828_RNA71762","GSM8797919","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P5828","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P5828_RNA71762","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858794","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697424","NONE","P5828","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P5956_RNA55274","GSM8797920","P5956_RNA55274","GSM8797920","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P5956","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P5956_RNA55274","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858793","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697425","NONE","P5956","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P5956_RNA82505","GSM8797921","P5956_RNA82505","GSM8797921","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P5956","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P5956_RNA82505","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858792","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697426","NONE","P5956","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P6365_RNA30271","GSM8797922","P6365_RNA30271","GSM8797922","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Responders","patient.id: P6365","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P6365_RNA30271","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858791","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697427","NONE","P6365","Responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P6365_RNA58601","GSM8797923","P6365_RNA58601","GSM8797923","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P6365","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P6365_RNA58601","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858790","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697428","NONE","P6365","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7043_RNA78744","GSM8797924","P7043_RNA78744","GSM8797924","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P7043","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7043_RNA78744","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858789","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697429","NONE","P7043","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7043_RNA80779","GSM8797925","P7043_RNA80779","GSM8797925","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P7043","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7043_RNA80779","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858788","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697430","NONE","P7043","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7043_RNA91214","GSM8797926","P7043_RNA91214","GSM8797926","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P7043","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7043_RNA91214","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858787","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697431","NONE","P7043","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7043_RNA98766","GSM8797927","P7043_RNA98766","GSM8797927","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Non-responders","patient.id: P7043","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7043_RNA98766","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858786","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697432","NONE","P7043","Non-responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7396_RNA54891","GSM8797928","P7396_RNA54891","GSM8797928","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P7396","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7396_RNA54891","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858785","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697433","NONE","P7396","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7396_RNA93981","GSM8797929","P7396_RNA93981","GSM8797929","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P7396","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7396_RNA93981","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858784","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697434","NONE","P7396","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7669_RNA15993","GSM8797930","P7669_RNA15993","GSM8797930","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Non-responders","patient.id: P7669","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7669_RNA15993","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858783","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697394","NONE","P7669","Non-responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7669_RNA25860","GSM8797931","P7669_RNA25860","GSM8797931","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P7669","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7669_RNA25860","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858782","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697395","NONE","P7669","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P7982_RNA68251","GSM8797932","P7982_RNA68251","GSM8797932","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P7982","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P7982_RNA68251","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858781","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697396","NONE","P7982","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8011_RNA38999","GSM8797933","P8011_RNA38999","GSM8797933","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P8011","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8011_RNA38999","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858780","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697397","NONE","P8011","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8011_RNA92097","GSM8797934","P8011_RNA92097","GSM8797934","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P8011","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8011_RNA92097","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858779","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697398","NONE","P8011","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8073_RNA89714","GSM8797935","P8073_RNA89714","GSM8797935","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P8073","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8073_RNA89714","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858778","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697399","NONE","P8073","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8088_RNA51412","GSM8797936","P8088_RNA51412","GSM8797936","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P8088","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8088_RNA51412","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858777","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697400","NONE","P8088","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8294_RNA74374","GSM8797937","P8294_RNA74374","GSM8797937","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P8294","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8294_RNA74374","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858776","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697401","NONE","P8294","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8362_RNA49996","GSM8797938","P8362_RNA49996","GSM8797938","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Non-responders","patient.id: P8362","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8362_RNA49996","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858775","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697402","NONE","P8362","Non-responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8485_RNA15819","GSM8797939","P8485_RNA15819","GSM8797939","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P8485","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8485_RNA15819","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858774","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697403","NONE","P8485","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8485_RNA18487","GSM8797940","P8485_RNA18487","GSM8797940","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P8485","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8485_RNA18487","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858773","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697404","NONE","P8485","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8485_RNA70944","GSM8797941","P8485_RNA70944","GSM8797941","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Non-responders","patient.id: P8485","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8485_RNA70944","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858772","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697405","NONE","P8485","Non-responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8485_RNA75819","GSM8797942","P8485_RNA75819","GSM8797942","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P8485","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8485_RNA75819","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858771","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697406","NONE","P8485","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8485_RNA96265","GSM8797943","P8485_RNA96265","GSM8797943","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P8485","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8485_RNA96265","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858770","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697407","NONE","P8485","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8658_RNA67816","GSM8797944","P8658_RNA67816","GSM8797944","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P8658","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8658_RNA67816","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858769","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697408","NONE","P8658","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8674_RNA53159","GSM8797945","P8674_RNA53159","GSM8797945","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P8674","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8674_RNA53159","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858768","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697409","NONE","P8674","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P8860_RNA59223","GSM8797946","P8860_RNA59223","GSM8797946","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Responders","patient.id: P8860","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P8860_RNA59223","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858767","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697410","NONE","P8860","Responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P9445_RNA14363","GSM8797947","P9445_RNA14363","GSM8797947","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P9445","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P9445_RNA14363","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858766","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697411","NONE","P9445","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P9445_RNA55962","GSM8797948","P9445_RNA55962","GSM8797948","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Pre-treatment","response: Non-responders","patient.id: P9445","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P9445_RNA55962","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858765","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697412","NONE","P9445","Non-responders","Pre-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
"P9445_RNA66983","GSM8797949","P9445_RNA66983","GSM8797949","Public on Aug 20 2025","Feb 16 2025","Aug 20 2025","SRA",1,"cutaneous squamous cell carcinoma FFPE tissue samples","Homo sapiens","tissue: cutaneous squamous cell carcinoma FFPE tissue samples","sample.collection.time: Post-treatment","response: Non-responders","patient.id: P9445","total RNA","The RNA extraction was performed with Mag-Bind® FFPE DNA/RNA 96 Kit (Omega Bio-Tek) following the manufacturer’s protocol. Isolated RNA sample quality was assessed by High Sensitivity RNA Tapestation (Agilent Technologies Inc., California, USA) and quantified by Qubit 2.0 RNA HS assay (ThermoFisher, Massachusetts, USA).","Libraries were constructed with KAPA™ RNA HyperPrep with RiboErase (Roche, Indiana, USA) and performed based on the manufacturer’s recommendations.",9606,"Library name: P9445_RNA66983","The paired-end reads in fastq format were initially checked for read quality using FastQC 0.11.8","Illumina universal adapters were trimmed from the reads using cutadapt 1.18 and read quality was checked again using FastQC 0.11.8","The trimmed reads were aligned to the Gencode GRCh38 human reference genome using STAR 2.7.0f","The BAM file with mapped reads for each sample was sorted and then used as an input for featureCounts (Subread 1.6.3) in order to generate read count data on gene/feature level (parameters: -p -t exon -g gene_id -s 2)","Genes/features were annotated using the GTF file from Gencode human GRCh38 reference","Assembly: Human GRCh38","Supplementary files format and content: Read count data generated by featureCounts (Subread 1.6.3) for each sample","GPL24676","Moran,,Amit","mamit@mdanderson.org","Head & Neck Surgery","University of Texas - MD Anderson Cancer Center","1515 Holcombe Blvd","Houston",77030,"USA",0,"Illumina NovaSeq 6000","cDNA","transcriptomic","RNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN46858764","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX27697413","NONE","P9445","Non-responders","Post-treatment","cutaneous squamous cell carcinoma FFPE tissue samples"
